ADHD Medication + Parent Training for ADHD Families

(TPAC Trial)

Not currently recruiting at 1 trial location
CD
AM
Overseen ByAndrea M Chronis-Tuscano, Ph.D.
Age: Any Age
Sex: Any
Trial Phase: Phase 3
Sponsor: University of Maryland, College Park
Must be taking: Stimulants
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the effectiveness of combining medication with parent training for families managing ADHD. One group of parents will receive a stimulant medication (extended-release mixed amphetamine salts) along with behavioral training, while another group will initially receive only the training. The study aims to determine if this combined approach can improve symptoms in both children and parents. Families with children showing signs of ADHD and parents diagnosed with ADHD might be suitable candidates. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to a potentially groundbreaking treatment.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on an antidepressant, it must be well-tolerated, unchanged for 30 days, and approved by your doctor for participation. If you have taken stimulant medication for ADHD in the past 30 days, you may not be eligible.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that Behavioral Parent Training (BPT) is safe and effective for families managing ADHD. Studies have found that BPT reduces parenting stress and improves children's behavior without major safety issues. Parents learn skills to help their children succeed at home and in school, which can significantly aid in managing ADHD symptoms.

Research indicates that extended-release mixed amphetamine salts (MAS) are generally well-tolerated by both children and adults with ADHD. Common side effects include trouble sleeping and dry mouth, but these are usually mild. MAS is already approved for treating ADHD, which supports its safety.

Previous research has shown that both treatments in this trial are safe for people with ADHD.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments for ADHD because they combine medication and behavioral training in a unique way. Unlike standard treatments that typically focus on either medication or behavioral therapy independently, this approach starts with parent stimulant medication followed by behavioral parent training. If needed, child stimulant medication is introduced next, allowing for a more tailored and potentially effective strategy. This dual focus aims to address ADHD symptoms more comprehensively by involving both parents and children in the treatment process. By doing so, this method could lead to better management of ADHD symptoms and improved family dynamics.

What evidence suggests that this trial's treatments could be effective for ADHD?

Research has shown that behavioral parent training (BPT) effectively reduces ADHD symptoms and related behavior issues in children. Studies indicate that BPT not only alleviates ADHD symptoms but also enhances parenting skills. Meanwhile, extended-release mixed amphetamine salts (MAS) have significantly improved ADHD symptoms. For example, many patients taking MAS experience a noticeable reduction in symptoms, with some studies finding that up to 75% of participants see significant improvement. In this trial, one arm will explore the combination of parent stimulant medication followed by a child treatment strategy involving BPT and potentially child stimulant medication. Another arm will focus on a child treatment strategy with BPT and potentially child stimulant medication, without prior parent stimulant medication. Both BPT and MAS show promising results for managing ADHD symptoms, and using them together might offer even greater benefits.16789

Who Is on the Research Team?

AC

Andrea Chronis-Tuscano, Ph.D.

Principal Investigator

University of Maryland, College Park

Are You a Good Fit for This Trial?

This trial is for parents over 21 with ADHD and their children aged 3-8 who may also have ADHD symptoms. Parents must meet full criteria for ADHD, be in good physical health, not pregnant, and agree to use contraception if applicable. Children should not have been on stimulant medications before or only tried them without success.

Inclusion Criteria

Parent: Be at least 21 years old and English-speaking, Meet full DSM-5 criteria for ADHD (any subtype), Have findings on physical examination, laboratory studies, vital signs, and electrocardiogram judged to be normal for age with no contraindications for stimulant medication, Have pulse and blood pressure (BP) within 95% of age and gender mean, Women of childbearing potential agree to use a medically accepted contraception method consistently, Parents with common comorbid conditions will be included provided that: (a) they do not report active suicidal ideation with intent (i.e. Beck Depression Inventory (BDI)-II score of 2 or 3 to Q9 which assesses suicidal thoughts); and (b) if receiving an antidepressant medication, their medication is well-tolerated, has not changed within 30 days, and the prescribing physician approves of their participation in the study, Must have regular access to a computer or phone that can be used to deliver the behavioral parent training
You have a CGI-S-ADHD rating ≥4 and <7.
My child is 3-8 years old, may or may not have tried ADHD meds, and shows significant ADHD symptoms.
See 3 more

Exclusion Criteria

- Parent has had severe negative reactions to study medications in the past or has a history of substance abuse within the last three months. - Parent has bipolar disorder, schizophrenia, psychoses, or other primary psychiatric disorder requiring immediate treatment. - Parent has a chronic or acute medical disorder that makes stimulant therapy unsafe, such as glaucoma or hypertension. - Parent has taken stimulant medication for ADHD within the last 30 days. - Parent is pregnant.
The child has very severe ADHD symptoms with a score of more than 6 on a scale called CGI-S-ADHD.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Parents receive stimulant medication and behavioral parent training, while children receive behavioral parent training with potential recommendation for stimulant medication

16 weeks
Telehealth sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

20 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Behavioral Parent Training
  • Extended release mixed amphetamine salts (MAS)
Trial Overview The study tests if combining a stimulant drug (MAS) for the parent with behavioral training improves child's ADHD-related issues more than just training alone. It will look at how this affects both the child’s behavior and the parent's ADHD symptoms when delivered via telehealth.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Parent Stimulant Medication + Child Treatment StrategyExperimental Treatment2 Interventions
Group II: Child Treatment StrategyActive Control1 Intervention

Behavioral Parent Training is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Behavioral Parent Training for:
🇪🇺
Approved in European Union as Parent Management Training for:
🇨🇦
Approved in Canada as Behavioral Parent Training for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, College Park

Lead Sponsor

Trials
163
Recruited
46,800+

Children's National Research Institute

Collaborator

Trials
227
Recruited
258,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Seattle Children's Hospital

Collaborator

Trials
319
Recruited
5,232,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

A study involving 92 parents of children with ADHD showed that brief training in either antecedent-based (AC) or consequent-based (CC) techniques significantly improved daily problem behaviors compared to a waitlist group.
Antecedent-based techniques were particularly effective in reducing inattention symptoms immediately after training and at a two-week follow-up, highlighting their importance in managing ADHD behaviors.
Which Techniques Work in Behavioral Parent Training for Children with ADHD? A Randomized Controlled Microtrial.Hornstra, R., van der Oord, S., Staff, AI., et al.[2022]
A randomized controlled trial involving 56 preschool children with ADHD showed that group-based behavioral parent training (BPT) is as effective as individual BPT in reducing ADHD severity over 12 weeks.
Both group and individual BPT significantly reduced parental stress and improved coping strategies, indicating that group BPT is a feasible and effective treatment option in low-resource settings.
Comparison of brief group behavioural parent training with individual parent training for preschool children with attention deficit hyperactivity disorder: A randomized feasibility study.Vaidyanathan, S., Chandrasekaran, V., Kandasamy, P.[2023]
Behavioral parent training (BPT) significantly reduced the frequency and severity of problematic behaviors in children with ADHD, particularly in areas like chores, homework, and peer interactions, based on data from 304 parents.
Parents reported a notable decrease in stress related to parenting their child with ADHD after participating in BPT, indicating that this intervention not only helps children but also supports parental well-being.
Behavioral Parent Training for ADHD Reduces Situational Severity of Child Noncompliance and Related Parental Stress.Ciesielski, HA., Loren, REA., Tamm, L.[2021]

Citations

Sustained improvements by behavioural parent training for ...We conclude that behavioural parent training has longer‐term benefits for children's ADHD symptoms and behavioural problems, and for positive ...
Internet-based behavioural parent training intervention for ...This study evaluates the efficacy of an 8-session internet-based BPT (I-BPT) program in improving ADHD symptoms and mental health outcomes for children and ...
Parent training for disruptive behavior symptoms in ...Parent training was effective in reducing symptoms of ADHD (p = 0.030) and ODD (p = 0.026) irrespective of modality (p = 1.000).
Parent training tailored for parents with ADHD: a randomized ...Behavioral parent training (BPT) is effective in helping parents improve their parental self-efficacy [17, 18] and develop parenting skills to ...
Effects of an 8-session Behavioral Parent Training Group ...This study replicates previous research showing that brief BPT group programs significantly improve the functional impairment of children with ADHD.
Behavior Management Training for Parents of Children ...The objective of this study was to explore a behavioral management training program aimed at the parents of preschool children with ADHD.
Efficacy of behavioural parent training on attachment security ...A Cochrane review [2] found that BPT was associated with improved parenting stress scores and general behaviour of children in the parent ...
Beneficial Effects of Behavioral Parent Training on ...In this study, we found that in addition to decreased ADHD symptoms and decreased negative parenting, the BPT group exhibited significantly ...
Parent Training in Behavior Management for ADHDWhen parents become trained in behavior therapy, they learn skills and strategies to help their child with ADHD succeed at school, at home, and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security